Orally delivered single-domain antibodies against gastrointestinal pathogens
- Chris Huynh
- Feb 23, 2023
- 1 min read
Updated: Sep 21, 2023
Petersson et al (2023) Trends in Biotech 41(7):P875-886
This publication describes how nanobodies can be orally administered and discusses the benefits and strengths of this platform.
Read full article here.
Comments